Correlation Between Humacyte and NRx Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Humacyte and NRx Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Humacyte and NRx Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Humacyte and NRx Pharmaceuticals, you can compare the effects of market volatilities on Humacyte and NRx Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Humacyte with a short position of NRx Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Humacyte and NRx Pharmaceuticals.
Diversification Opportunities for Humacyte and NRx Pharmaceuticals
-0.15 | Correlation Coefficient |
Good diversification
The 3 months correlation between Humacyte and NRx is -0.15. Overlapping area represents the amount of risk that can be diversified away by holding Humacyte and NRx Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NRx Pharmaceuticals and Humacyte is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Humacyte are associated (or correlated) with NRx Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NRx Pharmaceuticals has no effect on the direction of Humacyte i.e., Humacyte and NRx Pharmaceuticals go up and down completely randomly.
Pair Corralation between Humacyte and NRx Pharmaceuticals
Assuming the 90 days horizon Humacyte is expected to generate 5.6 times less return on investment than NRx Pharmaceuticals. But when comparing it to its historical volatility, Humacyte is 7.44 times less risky than NRx Pharmaceuticals. It trades about 0.1 of its potential returns per unit of risk. NRx Pharmaceuticals is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest 8.91 in NRx Pharmaceuticals on August 25, 2024 and sell it today you would lose (3.91) from holding NRx Pharmaceuticals or give up 43.88% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 90.53% |
| Values | Daily Returns |
Humacyte vs. NRx Pharmaceuticals
Performance |
| Timeline |
| Humacyte |
| NRx Pharmaceuticals |
Humacyte and NRx Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Humacyte and NRx Pharmaceuticals
The main advantage of trading using opposite Humacyte and NRx Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Humacyte position performs unexpectedly, NRx Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NRx Pharmaceuticals will offset losses from the drop in NRx Pharmaceuticals' long position.The idea behind Humacyte and NRx Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| NRx Pharmaceuticals vs. NRX Pharmaceuticals | NRx Pharmaceuticals vs. Relief Therapeutics Holding | NRx Pharmaceuticals vs. Quantum Si incorporated | NRx Pharmaceuticals vs. Reviva Pharmaceuticals Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Complementary Tools
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |